StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > And down we go again. Tripp the dummy.

<< Previous

Bullboard Posts

Next >>

Comment by frewil11on Feb 03, 2021 10:51am

159 Views

Post# 32457923

RE:And down we go again. Tripp the dummy.

The only thing I will agree with you is why have they not put out some releases on the great testing developments that the company has put together for COVID the only thing I can think of is they only want PR on Aristotle and not looked at as a COVID flash in the pan company.

<< Previous

Bullboard Posts

Next >>

Soma Gold poised to extend profitable track record